Trials / Sponsors / Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Dia Clostridium Difficile-Associated Diarrhea (CDAD) | Phase 3 | 2012-10-10 |
| Completed | Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-ass Clostridium Difficile-associated Diarrhea | Phase 2 | 2012-06-15 |
| Completed | Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers Acute Bacterial Gastroenteritis | Phase 3 | 2006-12-01 |
| Completed | PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) Clostridium Infections, Diarrhea | Phase 3 | 2006-10-04 |
| Completed | Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-0 Clostridium Infections, Diarrhea | Phase 3 | 2006-05-02 |
| Completed | OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD) Diarrhea | Phase 2 | 2004-11-01 |